WATERTOWN, Mass. and GOSSELIES, Belgium, Sept. 14, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and ...
A worker in charge of DNA analysis at the Saga Prefectural Police crime laboratory engaged in misconduct in a total of 130 ...
Depression is one of the most common mental illnesses. As many as 280 million people worldwide are affected by this disease, which is why researchers have developed an artificial intelligence (AI) ...
Innovative oral targeted therapies are warranted for patients with human epidermal growth factor receptor 2 (HER2)–mutant non–small-cell lung cancer (NSCLC). Zongertinib is an oral, irreversible, HER2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback